SEC Form 4 · accession 0001638599-17-001223
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Brooks Bass
Officer — EVP and Chief Commercial Offic
Period of report
Dec 6, 2017
Accepted (ET)
Dec 6, 2017 · 6:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $3.52 | Dec 6, 2017 | A | 75,000 | A | Dec 6, 2018 | Dec 6, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 6, 2018, while the remaining 2/3 of the shares subject to the award have vesting monthly on a prorata basis over the following two years.